CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
E Sun Paik, Insuk Sohn, Sun-Young Baek, Minhee Shim, Hyun Jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Yoo-Young Lee, Duk-Soo Bae
Cancer Research and Treatment. 2017;49(3):635-642.   Published online 2016 September 27    DOI: https://doi.org/10.4143/crt.2016.282

Excel Download

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
Cancer Research and Treatment. 2017;49(3):635-642   Crossref logo
Link1 Link2

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study
Yearbook of Oncology. 2009;2009:41-42   Crossref logo
Link1 Link2

The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer
Gynecologic Oncology. 2013;130(2):377-382   Crossref logo
Link1 Link2

Progression-free survival as a surrogate marker of overall survival
Cancer. 2011;117(12):2586-2587   Crossref logo
Link1

An evaluation of progression-free survival (PFS) and overall survival (OS) of ovarian cancer patients with clear cell carcinoma vs serous carcinoma treated with platinum therapy: A Gynecologic Oncology Group (GOG) experience
Gynecologic Oncology. 2014;133:26-27   Crossref logo
Link1 Link2

Progression-free survival and time to progression as real surrogate endpoints for overall survival in advanced breast cancer: A meta-analysis of 37 trials
Clinical Breast Cancer. 2017;   Crossref logo
Link1 Link2

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma
Cancer. 2013;120(1):52-60   Crossref logo
Link1

Pretreatment Complete Blood Count Parameters Are Prognostic Biomarkers for Overall Survival and Progression Free Survival in Patients Receiving Stereotactic Body Radiation Therapy for T1-T2 Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics. 2015;93(3):E439   Crossref logo
Link1 Link2

Effect of perioperative blood transfusion on quality of life, progression-free and overall survival in primary treatment of advanced epithelial ovarian cancer: An EORTC ancillary study
Gynecologic Oncology. 2016;141:198   Crossref logo
Link1 Link2

Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy
Free Radical Biology and Medicine. 2010;49(8):1263-1272   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.